Drug Profile
Research programme: erythropoietin depot - Borean Pharma
Alternative Names: Erythropoietin - BoreanLatest Information Update: 09 Aug 2007
Price :
$50
*
At a glance
- Originator Borean Pharma
- Class
- Mechanism of Action Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anaemia
Most Recent Events
- 09 Aug 2007 Discontinued - Preclinical for Anaemia in Denmark (Parenteral)
- 25 Feb 2004 Preclinical trials in Anaemia in Denmark (Parenteral)